Emergence of Antinuclear Antibodies in Psoriatic Patients Treated with Infliximab: Personal Experience and Literature Review

Drug Development Research

Volumn 75, Issue , 2014, Pages S61-S63

  Chimenti, Maria Sole ^a   Spinelli, Francesca Romana ^b   Giunta, Alessandro ^a   Martinelli, Francesco ^b   Saraceno, Rosita ^a   Conti, Fabrizio ^b   Perricone, Roberto ^a   Valesini, Guido ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

anti nuclear antibodies; anti TNF; disease activity; psoriasis

Indexed keywords

ANTINUCLEAR ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; INFLIXIMAB; IMMUNOGLOBULIN M; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; CLINICAL ARTICLE; DRUG SAFETY; DRUG TREATMENT FAILURE; FEMALE; HUMAN; MALE; PERSONAL EXPERIENCE; PSORIASIS; PSORIASIS AREA AND SEVERITY INDEX; REVIEW; ANTAGONISTS AND INHIBITORS; CLINICAL TRIAL; IMMUNOLOGY; MIDDLE AGED;

ADULT; AGED; ANTIBODIES, ANTINUCLEAR; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; PSORIASIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84910070567     PISSN: 02724391     EISSN: 10982299     Source Type: Journal    
DOI: 10.1002/ddr.21198     Document Type: Review

References (6)

1. Alessandri C, Scrivo R, Spinelli FR, Ceccarelli F, Magrini L, Priori R, Valesini G,. 2007. Autoantibody production in anti-TNF-alpha-treated patients. Ann N Y Acad Sci 1110: 319-329.
2. Hoffmann JH, Hartmann M, Enk AH, Hadaschik EN,. 2011. Autoantibodies in psoriasis as predictors for loss of response and anti-infliximab antibody induction. Br J Dermatol 165: 1355-1358.
3. Lora V, Bonaguri C, Gisondi P, Sandei F, Battistelli L, Russo A, Melegari A, Trenti T, Lippi G, Girolomoni G,. 2013. Autoantibody induction and adipokine levels in patients with psoriasis treated with infliximab. Immunol Res 56: 382-389.
4. Papoutsaki M, Osõrio F, Morais P, Torres T, Magina S, Chimenti S, Costanzo A,. 2013. Infliximab in psoriasis and psoriatic arthritis. Biodrugs 27 (Suppl. 1): 13-23.
5. Poulalhon N, Begon E, Lebbé C, Lioté F, Lahfa M, Bengoufa D, Morel P, Dubertret L, Bachelez H,. 2007. A follow-up study in 28 patients treated with infliximab for severe recalcitrant psoriasis: evidence for efficacy and high incidence of biological autoimmunity. Br J Dermatol 156: 329-336.
6. Saraceno R, Specchio F, Torres T, Nisticò SP, Rizza S, Chimenti S,. 2012. The role of antinuclear autoantibodies in patients with psoriasis treated with anti-tumor necrosis factor-alpha agents: a retrospective long-term study. J Am Acad Dermatol 66: 180-182.